Zuckerman B - Search Results

1

VARC consensus report: the FDA perspective.

Hillebrenner MG, Swain JA, Zuckerman B. Hillebrenner MG, et al. Among authors: zuckerman b. J Am Coll Cardiol. 2011 Jan 18;57(3):270-1. doi: 10.1016/j.jacc.2010.12.004. Epub 2011 Jan 7. J Am Coll Cardiol. 2011. PMID: 21216554 Free article. No abstract available.

2

Cardiovascular device development: an FDA perspective.

Zuckerman BD, Muni NI. Zuckerman BD, et al. Am J Ther. 2005 Mar-Apr;12(2):176-8. doi: 10.1097/01.mjt.0000155115.66222.3c. Am J Ther. 2005. PMID: 15767836 No abstract available.

3

FDA perspective on clinical trial design for cardiovascular devices.

Chen E, Sapirstein W, Ahn C, Swain J, Zuckerman B. Chen E, et al. Among authors: zuckerman b. Ann Thorac Surg. 2006 Sep;82(3):773-5. doi: 10.1016/j.athoracsur.2006.07.044. Ann Thorac Surg. 2006. PMID: 16928481 No abstract available.

4

US FDA perspective on regulatory issues affecting circulatory assist devices.

Sapirstein W, Chen E, Swain J, Zuckerman B. Sapirstein W, et al. Among authors: zuckerman b. Expert Rev Med Devices. 2006 Nov;3(6):749-53. doi: 10.1586/17434440.3.6.749. Expert Rev Med Devices. 2006. PMID: 17280539

5

FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

Kumar A, Brooks SS, Cavanaugh K, Zuckerman B. Kumar A, et al. Among authors: zuckerman b. J Vasc Surg. 2009 Dec;50(6):1474-6. doi: 10.1016/j.jvs.2009.09.045. Epub 2009 Nov 7. J Vasc Surg. 2009. PMID: 19897334 Free article. Review.

6

Interventional cardiology live case presentations: regulatory considerations.

Farb A, Brown SA, Wolf DA, Zuckerman B. Farb A, et al. Among authors: zuckerman b. J Am Coll Cardiol. 2010 Oct 5;56(15):1283-5. doi: 10.1016/j.jacc.2010.08.601. J Am Coll Cardiol. 2010. PMID: 20883943 Free article. No abstract available.

7

VARC consensus report: the FDA perspective.

Hillebrenner MG, Swain JA, Zuckerman B. Hillebrenner MG, et al. Among authors: zuckerman b. Eur Heart J. 2011 Jan;32(2):138-9. doi: 10.1093/eurheartj/ehq414. Epub 2011 Jan 6. Eur Heart J. 2011. PMID: 21216740 Free PMC article. No abstract available.

8

Food and Drug Administration commentary on "a new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves".

Aguel F, Kurtzman SB, Patel-Raman S, Hillebrenner M, Zuckerman BD. Aguel F, et al. Among authors: zuckerman bd. J Thorac Cardiovasc Surg. 2013 Oct;146(4):887. doi: 10.1016/j.jtcvs.2013.06.003. Epub 2013 Jul 16. J Thorac Cardiovasc Surg. 2013. PMID: 23870153 Free article. No abstract available.

9

Mitral Valve Academic Research Consortium Consensus Report: The U.S. Food and Drug Administration Perspective.

Laschinger JC, Ibrahim NG, Zuckerman BD. Laschinger JC, et al. J Am Coll Cardiol. 2015 Jul 21;66(3):322-323. doi: 10.1016/j.jacc.2015.05.045. J Am Coll Cardiol. 2015. PMID: 26184624 Free article. No abstract available.

10

New technology in electrophysiology: FDA process and perspective.

Selzman KA, Fellman M, Farb A, de Del Castillo S, Zuckerman B. Selzman KA, et al. Among authors: zuckerman b. J Interv Card Electrophysiol. 2016 Oct;47(1):11-18. doi: 10.1007/s10840-016-0127-4. Epub 2016 Mar 28. J Interv Card Electrophysiol. 2016. PMID: 27020440 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page